Table 1.
Africa.
| Country | Sudan | Nigeria | Kenya | Tunisia | Tanzania | |||
|---|---|---|---|---|---|---|---|---|
| Author | Awadelkarim [22] | Ipkatt [23] | Huo [24] | Adebamowo [25] | Bird [26] | Maalej [27] | Mbonde [28] | |
| N = | 114 | 285 | 378 | 192 | 129 | 1437 | 60 | |
| Mean/Median Age (yrs) at presentation | 52 | 43 | 45 | - | 48 | 51 | 52 | |
| Mean/Median Tumour Size (mm) | 48 | 48 | 55% (21–40 mm) |
- | 68 (clinical) |
33 | 70%>51 | |
| Histology | IDC | 90% | - | 87% | 82% | 90 | 87% | 78% |
| ILC | 5% | 4% | 4% | 2% | - | - | 15% | |
| Grade | 1 | 1% | 55% | 17% | 9% | 16% | 9% | 25% |
| 2 | 31% | 38% | 44% | 34% | 55% | 47% | ||
| 3 | 68% | 45% | 44% | 16% | 50% | 35% | 28% | |
| Stage | 1 | 62% | 47% * - |
- | 5% | 8% (Stage 0–1) |
- | - |
| 2 | - | 10% | 30% | - | 7% | |||
| 3 | 38% | 53% * - |
- | 38% | 46% | - | 63% | |
| 4 | - | 48% | 17% | - | 30% | |||
| LN+ | 90% | - | 72% | - | 72% | 57% | - | |
| ER+ | 64% | - | 24% | 65% | 24% | 57% | 33% | |
| PR+ | 67% | - | 20% | 55% | - | 54% | 18% | |
*
Clinical stage; - Information not available.